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A B S T R A C T
Globins are among the best investigated proteins in biological and medical sciences and represent a prime tool
for the study of the evolution of genes and the structure-function relationship of proteins. Here, we explore the
recombinant expression of globins in three diﬀerent expression systems: Escherichia coli, Pichia pastoris and the
baculovirus infected Spodoptera frugiperda. We expressed two diﬀerent human globin types in these three ex-
pression systems: I) the well-characterized neuroglobin and II) the uncharacterized, circular permutated globin
domain of the large chimeric globin androglobin. It is clear from the literature that E.coli is the most used
expression system for expression and puriﬁcation of recombinant globins. However, the major disadvantage of E.
coli is the formation of insoluble aggregates. We experienced that, for more complex multi-domain globins, like
the chimeric globin androglobin, it is recommended to switch to a higher eukaryotic expression system.
Introduction
Globins can be deﬁned as small heme-containing proteins which can
mostly reversibly bind oxygen. They occur in the three kingdoms of life:
Archaea, Prokaryotes and Eukaryotes and exist as single domain or
chimeric proteins [1,2]. The best known single domain globins are the
vertebrate hemoglobin (Hb) and myoglobin (Mb), playing respectively
a role in oxygen transport and storage. Examples of chimeric globins are
the ﬂavohemoglobins (FHbs) in Escherichia coli and yeast, consisting of
an N-terminal globin domain coupled to a ferredoxin reductase-like
domain [3], and the globin coupled sensors (GCS), reported in Bacteria
and Archaea, comprising an N-terminal globin domain linked to vari-
able gene regulatory domains [4]. FHbs and GCS do not occur in ver-
tebrates. The recent and rapid accumulation of genomic information
has resulted in a substantial increase in newly recognized globins.
Bioinformatic genome surveys revealed that more than 50% of the
bacterial, approximately 20% of the archaeal and almost 90% of the
eukaryote genomes contain genes encoding globins [1,5–7]. Despite
their great variety in function and amino acid sequence, most of them
share a similar three-dimensional structure, referred to as the globin
fold, characterized by a three-over-three alpha helical folding. Few
globins, however, display a two-over-two alpha helical folding and are
called ‘truncated globins’ [8].
Globins are among the most investigated proteins in biological and
medical sciences and represent a major tool for the study of gene
evolution and structure-function relationship of proteins. Sperm whale
Mb was the ﬁrst protein of which the three-dimensional structure was
revealed by X-ray crystallography [9]. The structure of human Hb fol-
lowed ﬁve years later [10]. In the early times of protein crystallization
and structure determination, the investigated proteins were puriﬁed
from their natural context, e.g. Mb out of sperm whale muscle tissue
and Hb out of human erythrocytes. However, under normal physiolo-
gical conditions, most proteins are present in low cellular concentra-
tions and cannot be puriﬁed out of the tissue itself. Since the early
eighties it is has been possible to express proteins recombinantly in
heterologous host cells like the bacterium Escherichia coli (E.coli)
[11,12] or the yeast Saccharomyces cerevisiae (S.cerevisiae) [13]. These
host cells can produce a large amount of recombinant protein, that
enables the characterization of proteins with a low cellular abundance.
In addition, this technique facilitates the study of protein-function re-
lationships by site-directed mutagenesis. This revolution in protein
biochemistry caused an exponential increase in knowledge on the
structure and function of proteins in general.
Neuroglobin (Ngb) was ﬁrst described in 2000 as a vertebrate
globin, preferentially expressed in brain and other nerve tissue [14].
The estimated amount of Ngb in the vertebrate brain under non-pa-
thological conditions is only in the micromolar range. It was possible to
perform a biochemical and structural characterization of NGB sub-
sequent to the recombinant expression of the protein in E.coli [15].
Androglobin (Adgb) was described in 2012 as the ﬁfth mammalian
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globin type (in addition to Hb, Mb, Ngb and cytoglobin (Cygb)) and it
displays predominant expression in testis tissue in mice and human
[16]. Adgb characteristically comprises four domains, an N-terminal
∼350 residues calpain-like cysteine protease domain, a region of∼300
residues without known motifs/domains, followed by an∼150 residue
circularly permutated globin domain, and a second, uncharacterized
∼750 residues C-terminal domain. Interestingly, the globin domain,
which normally consists of eight consecutive α-helices (named A-H), is
circularly permutated and split into two parts within Adgb. The part
containing helices A and B has been shifted in the C-terminal direction
and is separated from the main globin sequence (helices C–H) by a
calmodulin-binding IQ motif. Alignments of the split Adgb globin do-
main with mammalian Mb, Ngb, and Cygb sequences revealed that
Adgb—despite its rearrangement—conforms to the criteria of the
‘‘globin fold’’ tertiary structure [16]. This was conﬁrmed by molecular
modelling of the human Adgb (ADGB) globin domain 3D structure,
showing that the helix C–H segment alone is able to produce a bona ﬁde
globin fold [16]. In vitro structural and functional analysis of ADGB is
necessary to better understand its molecular function during sperma-
togenesis, for which a recombinant form of ADGB is required.
In this paper, we explore three diﬀerent expression systems for the
expression of globins: a bacterial (E.coli), a yeast (Pichia pastoris
(P.pastoris)) and an insect cell expression system (baculovirus infected
Sf9). These three expression systems are widely used and in previous
studies they have been compared for their recombinant expression of
e.g. G-protein-coupled receptors [17], endostatin [18] and rabbit liver
carboxylesterases [19]. We investigate their advantages and dis-
advantages for the expression of globins in general. Furthermore, we
used these three diﬀerent expression systems to express the two dif-
ferent human globin types that were described above: I) the single
domain globin neuroglobin (NGB), which has already been biochemi-
cally and structurally characterized and II) the uncharacterized chi-
meric globin ADGB.
Material and methods
Construction of the recombinant expression vectors
The cDNA sequence of the globin domain of human ADGB (referred
to as CH-IQ-AB) and human NGB were cloned into the recombinant
expression vectors pET23a (E.coli), pPicZα (P.pastoris) and pDEST10
(Spodoptera frugiperda 9 (Sf9)). The cDNA of full length ADGB was only
cloned into the pDEST10 vector (Table 1). Full length ADGB was RT-
PCR ampliﬁed, with NcoI and XbaI overhangs (Table 2) from human
testis cDNA and cloned into the pENTR4 vector. The CH-IQ-AB domain
was PCR-ampliﬁed for further cloning from the pENTR4 ADGB vector.
The NGB domain was PCR-ampliﬁed from pET3a NGB construct, which
was already available in our laboratory [15]. For the cloning of CH-IQ-
AB in the pPicZα vector, the cDNA of the fragment was synthesized by
Invitrogen GeneArt, with optimized codons for expression in P.pastoris.
The ampliﬁcations of the fragments coding for the CH-IQ-AB and
NGB were performed by PCR. PCR ampliﬁcation was performed as
follows: initial denaturation at 94 °C for 5 min, followed by 35 cycles
(94 °C 1 min; 55 °C 1 min; 72 °C 1min) and a ﬁnal elongation at 72 °C
for 10 min. The forward and reverse primers sequences, including re-
striction sites/attB recombination sites, were in house designed and are
listed in Table 2. Recombinant pET23a CH-IQ-AB, pET23a NGB, pPicZα
CH-IQ-AB and pPicZα NGB were created using standard restriction
enzyme cloning. Two mutations were made in the pET23a CH-IQ-AB
construct resulting in the replacement of two cysteines (on position C3
and E2) using the QuikChange™ site-directed mutagenesis method
(Stratagene). The recombinant pDEST10 CH-IQ-AB and pDEST10 NGB
vector were created using the Gateway cloning technique: ﬁrst a pENTR
CH-IQ-AB and pENTR NGB vector were created by a BP recombination
reaction between attB CH-IQ-AB/NGB PCR product and pDONR221
vector and second the pDEST10 NGB and pDEST10 CH-IQ-AB were
created by a LR recombination reaction between pENTR CH-IQ-AB/
pENTR NGB vector and the pDEST10 vector. The pDEST10 ADGB (full
length) was created using the Gateway cloning technique: LR re-
combination reaction between pENTR4 ADGB and the pDEST10 vector.
The constructed recombinant expression vectors were veriﬁed via di-
rect sequencing.
Expression in Escherichia coli
pPET23a CH-IQ-AB and pPET23a NGB were transformed into
competent E.coli BL21(DE3)pLysS cells. Subsequently, cells were grown
in a shaking incubator (160 rpm) at 25 °C in TB medium (1.2% bac-
totryptone, 2.4% yeast extract, 0.4% glycerol, 72 mM potassium
phosphate buﬀer, pH7.5) containing 200 μg/ml ampicillin, 30 μg/ml
chloramphenicol, and 1 mM δ-amino-levulinic acid. The expression of
the C-terminal His-tagged fusion proteins was induced at A550nm = 0.8
by the addition of isopropyl-1-thio-D-galactopyranoside (IPTG) to a
ﬁnal concentration of 0.4 mM, and expression was continued overnight.
The cells were harvested and resuspended in ∼1/20 of the initial vo-
lume (resuspention buﬀer = 50 mM Tris-HCl pH8.0, 300 mM NaCl).
The cells were then exposed to three freeze-thaw steps and were soni-
cated until completely lysed. The extract was clariﬁed by centrifugation
(12000g, 10min, 4 °C) and both supernatant and pellet fraction were
screened for expression of recombinant protein (CH-IQ-AB, NGB) using
SDS-PAGE.
Expression in Pichia pastoris
pPicZα CH-IQ-AB and pPicZα NGB were linearized with restriction
endonuclease SacI and subsequently 5 μg plasmid was transformed into
P.pastoris X33 electrocompetent cells by electroporation: cells were
pulsed using the manufacturer's instructions for Saccharomyces cerevi-
siae (Bio-rad electroporation system). Transformed cells were plated out
on YPDS agar plates (1% yeast extract, 2% peptone, 2% dextrose, 1M
sorbitol, 2% agar) containing 100 μg/ml Zeocin and were incubated 4
days at 30 °C. The Mut Phenotype was determined by streaking the
colonies out on both MD (1,34% YNB, 4 × 10−5% biotin, 2% dextrose)
and MM (1,34% YNB, 4 × 10−5% biotin, 0,5% methanol) agar plates
containing 100 μg/ml Zeocin. 8 Mut+ colonies, of which the presence
of the insert was conﬁrmed by PCR using the recommended sequencing
primers, were inoculated in 25 ml BMGY medium (1% yeast extract, 2%
peptone, 100 mM potassium phosphate pH6.0, 1.34% Yeast Nitrogen
Base, 4 × 10−5% biotin, 1% glycerol) and grown overnight at 30 °C in
a shaking incubator (200 rpm) until they reached an OD600 = 2–5.
Subsequently, the cells were harvested by centrifugation (2000g,
10min, RT) and the cell pellet was resuspended to an OD600 of 1 in
BMMY medium (1% yeast extract, 2% peptone, 100 mM potassium
phosphate pH6.0, 1.34% Yeast Nitrogen Base, 4 × 10−5% biotin, 0.5%
methanol) containing 1 mM δ-amino-levulinic acid and further grown
at 30 °C in a shaking incubator (200 rpm). Methanol will induce the
expression of the C-terminal His-tagged proteins, so every 24 h 100%
methanol was added to ﬁnal concentration of 0.5% to maintain in-
duction. 1 ml of expression culture was collected every 24 h to analyze
expression levels with Western blot. For this, the cells were centrifuged
(4000g, 20min, RT); the supernatant was screened for secreted ex-
pression of recombinant protein; the cell pellet was resuspended in SDS-
loading buﬀer and screened for intracellular expression. After 96 h all
Table 1
Overview of the diﬀerent expression vectors used in this paper.
Vector Tag Promoter Expression host
pET23a 6xHis, C-terminal T7 Escherichia coli BL21(DE3)pLysS
pPicZα 6xHis, C-terminal AOX Pichia pastoris X33
pDEST10 6xHis, N-terminal Polyhedrin Spodoptera frugiperda Sf9
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cells were harvested by centrifugation (4000g, 20min, RT).
Expression in Spodoptera frugiperda 9 insect cells
pDEST10 CH-IQ-AB, pDEST10 NGB and pDEST10 ADGB were
transformed into MAX Eﬃciency® DH10Bac™ competent E.coli
(ThermoScientiﬁc™) to generate recombinant baculovirus DNA. The
presence of the insert in the baculovirus DNA was veriﬁed by PCR using
the recommended sequencing primers. 1 μg of pure recombinant ba-
culovirus DNA was subsequently transfected into Sf9 insect cells
(ThermoScientiﬁc™) using Cellfectin® II reagent (ThermoScientiﬁc™)
following the manufacturers guidelines. Sf9 cells were maintained and
passaged adherently in cell culture ﬂasks at 28 °C with loose caps to
allow gas exchange, the cells were cultured in Grace's Insect Cell
Culture Medium (ThermoScientiﬁc™), supplemented with 10% fetal
bovine serum (FBS) and 5% Penicillin/Streptomycin. After transfection,
cells were incubated at 28 °C for 72 h until signs of viral infections
could be seen. Recombinant virus particles were harvested by collecting
the medium. The recombinant baculoviral stock was ampliﬁed three
times (P3). Finally, Sf9 cell cultures (Grace's Insect Cell medium sup-
plemented with 10% FBS, 5% Penicillin/Streptomycin, 1 mM δ-amino-
levulinic acid, 14 μM E64, 0.15 μM Pepstatin A, 4 μM CalpainII
Inhibitor) were infected with P3 recombinant virus particles and were
incubated for 72 h at 28 °C. Proteins were extracted by resuspending
cells in native lysis buﬀer (25 mM sodium phosphate (pH 7.0), 150 mM
NaCl, 1% NP40), followed by centrifugation (12000g, 20min, 4 °C).
Expression was screened using Western blot.
Puriﬁcation
Puriﬁcation NGB
20 mM imidazole was added to the clariﬁed cell lysates of E.coli or
to the cell medium of P.pastoris, prior to loading onto a Ni Sepharose™
High Performance column (GE Healthcare), pre-equilibrated with
equilibration buﬀer (50 mM Tris-HCl pH7.5, 300 mM NaCl, 20 mM
imidazole). Bound proteins were eluted with elution buﬀer (50 mM
Tris-HCl pH7.5, 300 mM NaCl, 250 mM imidazole). The fractions
containing the pure recombinant protein were pooled, dialyzed against
the proper buﬀer (50 mM Tris-HCl pH8.5, 150 mM NaCl, 0.5 mM
EDTA) and concentrated.
Puriﬁcation CH-IQ-AB
CH-IQ-AB was puriﬁed under denaturing conditions. 8M urea was
added to the cell lysate of E.coli and the recombinant protein was
puriﬁed under denaturing conditions (8M urea was added to equili-
bration and elution buﬀer). Subsequently, the immobilized nickel aﬃ-
nity chromatography was carried out as described above. Afterwards,
the pure unfolded recombinant CH-IQ-AB was refolded in vitro by dia-
lysis towards a buﬀer without urea (50 mM Tris-HCl pH8.5, 150 mM
NaCl, 0.5 mM EDTA) and by adding an excess of free heme before
starting dialysis (end concentration of 1M hemine). Subsequently, non-
incorporated heme was removed by gel ﬁltration (Sephaycryl S200
column, running buﬀer = 50 mM Tris-HCl pH8.5, 150 mM NaCl,
0.5 mM EDTA).
Optical absorption spectra
To verify a correct heme-incorporation of the puriﬁed recombinant
globin, UV/visible spectra were taken (200 nm–700 nm). Spectral
measurements were made with a spectrophotometer (Shimadzu UV-
2101PC). The ferrous deoxy sample was obtained by adding an excess
of sodium dithionite.
SDS-page and Western blot analysis
Samples were ﬁrst denatured and reduced by the addition of an
equal amount of loading buﬀer (4% SDS, 10% v/v β-mercapto-ethanol,
125 mM TRIS-HCl pH6.8, 20% glycerol) and by incubating them at
95 °C for 5min. Subsequently, equal mass samples were separated by
SDS-PAGE (15% acrylamide gel for NGB and CH-IQ-AB and 7,5% ac-
rylamide for ADGB). For SDS-PAGE analysis, proteins were stained with
Coomassie Brilliant Blue G-250. For Western blot analysis, proteins
were transferred to polyvinylidene diﬂuoride (PVDF) membranes ac-
cording to the manufacturer's instructions (Immobilon®-P PVDF mem-
brane, pore size 0.45 μm, Millipore). The membranes were probed with
mouse-derived anti-His Tag antibody (6x-His Tag Monoclonal Antibody
(4E3D10H2/E3) Invitrogen) or anti-ADGB antibody (polyclonal anti-
ADGB antibody HPA036340 SIGMA) (1:5000 in 5% Milk TBS buﬀer);
overnight at 4 °C, followed by an incubation at room temperature for
1 h with an HRP-conjugated antibody (1:5000 in TBS) (Polyclonal Goat
anti-mouse/rabbit Immunoglobulins – HRP, DAKO). Subsequently,
Luminata Forte Western HRP substrate (Millipore) was added to the
membrane and the targeted proteins were visualized using a SynGene
imager.
Table 2
Overview of the in-house designed primers for the cloning of the diﬀerent recombinant expression vectors. Bold = RE recognition site or mutated codon, underlined = KeX2 cleavage
site.
Primer Sequence Restriction site/attB
ADGB pENTR4F CATGCCATGGGCTCAGAGCTCAGCCCTACA NcoI
ADGB pENTR4R TGCTCTAGAGCATGGACATCCCCTGGTTACTT XbaI
NGB pET23a F GGGAATTCCATATGGAGCGCCCGGAGCCCGAG NdeI
NGB pET23a R CCGCTCGAGCTCGCCATCCCAGCCTCG XhoI
CH-IQ-AB pET23a F GGGAATTCCATATGCACATCTGCAGC ATGGTG NdeI
CH-IQ-AB pET23a R CCGCTCGAGGCTTTTAAACATTAGTCT XhoI
NGB pPicZα F CCGCTCGAGAAAAGAGAGGCTGAAGCTATGGAGCGCCCGGAGCCCGAGCTG XhoI KeX2 cleavage site
NGB pPicZα R CTAGTCTAGAGGCTCGCCATCCCAGCCTCGAC XbaI
CH-IQ-AB pPicZα R CCG CTCGAGAAAAGAGAGGCTGAAGCTCACATCTGCAGC ATGGTG XhoI KeX2 cleavage site
CH-IQ-AB pPicZα R CTAGTCTAGAGCTTTTAAACATTAGTCT XbaI
NGB pDONR F GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGAGCGCCCGGAGCCCGAGCTG attB1
NGB pDONR R GGGGACCACTTTGTACAAGAAAGCTGGGTTTACTCGCCATCCCAGCCTCGACTCATG attB2
CH-IQ-AB pDONR F GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCACATCTGCAGCATGGTGTCATTTG attB1
CH-IQ-AB pDONR R GGGGACCACTTTGTACAAGAAAGCTGGGTTTAGCTTTTAAACATTAGTCTTAAG attB2
CH-IQ-AB Cys C3 F CATATGCACATCTCCAGCATGGTGTCA Cys → Ser
CH-IQ-AB Cys C3 R TGACACCATGCTGGAGATGTGCATATG Cys → Ser
CH-IQ-AB Cys E2 F GAACCAGAGAGCTCCCGATTTACGGAA Cys → Ser
CH-IQ-AB Cys E2 R TTCCGTAAATCGGGAGCTCTCTGGTTC Cys → Ser
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Results and discussion
Recombinant expression in Escherichia coli
The by far most popular host for recombinant protein expression is
E.coli: 86% of the protein structures entered in the protein databank
(PDB) [20] were expressed recombinantly in E.coli. This can be ex-
plained by the fact that, for a large scale protein production, the E.coli
system is the easiest, quickest and cheapest method. There are many
commercial and non-commercial expression vectors available with
diﬀerent N- and C-terminal tags and many diﬀerent E.coli strains, which
are optimized for special applications. The ﬁrst globins recombinant
expressed in E.coli were human Mb [21] and Hb [12], followed rapidly
by many other globin types of many diﬀerent organisms. In most cases,
globins are small globular proteins, with no speciﬁc requirements in
folding or post-translational processing and thus E.coli is often the
perfect host for their large scale recombinant expression.
However, the high degree of accumulation of soluble protein during
recombinant expression is not always accepted by the metabolic system
of the host. Sometimes, the recombinant expressed protein is toxic to
the host cell and causes a cellular stress response, which results in poor
and irregular protein expression. An example of such a situation is the
expression of microbial FHbs. These chimeric globins possess the ability
to generate superoxide and peroxide in the presence of reductant and
NAD(P)H and the accumulation of these reactive oxygen species are
toxic to the host cell. These problems can be overcome by expressing
the FHbs under the control of an inducible promoter. Lewis et al. used
the pBAD expression system, which allows tightly controlled, titratable
expression of a protein through the regulation of arabinose concentra-
tion [22].
Another often encountered problem is the accumulation of target
proteins into insoluble aggregates known as inclusion bodies. These
proteins are misfolded and biologically inactive. Aggregation prone
proteins require the existence of a number of molecular chaperones that
interact reversibly with nascent polypeptide chains to prevent ag-
gregation during the folding process. The formation of inclusion bodies
could therefore result either from accumulation of high concentrations
of folding intermediates or from ineﬃcient processing by molecular
chaperones [23]. Refolding from inclusion bodies is in many cases
considered undesirable as it results most of the time in a poor recovery
of bio-active protein [24]. Most used strategies for shifting the re-
combinant expression from inclusion bodies to soluble protein are:
changing the expression temperature, media and transcription rates,
trying various E.coli strains, including molecular chaperones, including
tRNA complementation plasmids, expressing fragments, using fusion
technology, stabilizing mRNA or screening for soluble variants. For
further reading on these strategies we refer to the review paper of
Sorensen et al. [23].
The formation of inclusion bodies during recombinant globin ex-
pression is a frequently encountered problem. The ﬁrst recombinant
Fig. 1. A) SDS-PAGE (15%): Recombinant expression in E.coli of CH-IQ-AB (∼25 kDa) and NGB (∼18 kDa). I) E.coli total cell lysate II) Insoluble fraction of cell lysate III) Soluble fraction
of cell lysate IV) Fraction after native puriﬁcation with Nickel column. B) Optical absorption spectra of NGB expressed in E.coli (pET23a) and C) optical absorption spectra of refolded CH-
IQ-AB, expressed in E.coli (pET23a).
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expressed globins (Mb and Hb) were expressed as inclusion bodies and
refolded in vitro into their functional form [12,21]. Nevertheless, by
changing expression conditions most globins can be expressed and
puriﬁed as soluble proteins [25].
Expression of NGB and CH-IQ-AB in E.coli
For the recombinant expression of human NGB and the globin do-
main of human ADGB (referred to as CH-IQ-AB) in E.coli we cloned
them into the pET23a expression vector, which uses the strong in-
ducible T7 promotor. The recombinant pET23a constructs were subse-
quently transformed in BL21(DE3)pLysS E.coli, where the recombinant
expression was induced by the addition of isopropyl β-D-1-thioga-
lactopyranoside (IPTG). pET23a expresses the proteins with a C-term-
inal His-tag, which binds to several types of immobilized metal ions,
like nickel. His-tagged proteins can thus easily be puriﬁed using nickel
aﬃnity chromatography. Both the soluble and insoluble fractions of the
cell lysate were screened using SDS-PAGE for the recombinant over-
expression of NGB and CH-IQ-AB (Fig. 1A).
NGB was expressed in a soluble form and was puriﬁed with nickel
aﬃnity chromatography. After puriﬁcation of NGB, optical absorption
spectra were recorded, which were characteristic for NGB [15]. NGB is
a hexacoordinated globin which means that under deoxy conditions the
protein forms two coordinative bonds with the iron atom of the heme
group. The optical absorption spectrum of a hexacoordinated heme
group has large amplitudes for the alpha band (562 nm) and the Soret
band (428 nm). This observation indicates that the heme group was
correctly incorporated in the polypeptide chain of NGB (Fig. 1B), con-
sistent with a previous report [15].
CH-IQ-AB was expressed in E.coli as insoluble aggregates, also
known as inclusion bodies and it was not possible to purify CH-IQ-AB as
a soluble protein even after alternating the conditions (Fig. 1A). Dif-
ferent strategies were used to shift the expression from inclusion bodies
to stable soluble protein. By changing time of induction and lowering
the temperature during protein expression we were able to avoid in-
clusion body formation, however CH-IQ-AB remained unstable and
precipitated over time. We tried to increase the solubility of the globin
domain by the addition of reducing agents or detergents and by chan-
ging the pH or salt concentrations of the resuspension buﬀer. Because
CH-IQ-AB possesses two cysteine residues, which can possibly cause
intermolecular disulﬁde bridge formation and hence precipitation, we
mutated the cysteines into serines. Despite these eﬀorts, CH-IQ-AB re-
mained unstable. As such, CH-IQ-AB was expressed as inclusion bodies,
puriﬁed under denaturing conditions (8M urea) and the recombinant
protein was refolded in vitro by dialysis and adding free heme, as pre-
viously done for human CYGB [26]. In contrast to the predictions of the
computer three-dimensional modeling [16] the refolded globin domain
was not stable and precipitated over time. Despite the precipitation, we
were able to measure an UV-visible spectrum of the refolded globin
domain. The optical absorption spectra of the refolded ferrous deoxy
CH-IQ-AB domain displayed the typical spectra of a hexacoordinated
globin (high α band (557 nm) and Soret band (421 nm), low beta band
(527 nm)), like NGB (Fig. 1C). However, the puriﬁcation of the refolded
CH-IQ-AB was not eﬃcient and only low yields could be obtained. The
refolded globin domain remained unstable, precluding biophysical
characterizations, including ligand binding kinetic determination and
crystallization.
Folding studies of apomyoglobin (apoMb) [27] and plant he-
moglobins [28] showed that the folding of a globin happens based on
the contact order of not only local-residue contacts (as is seen with very
small proteins), but also on long-range amino acid interactions. A
stepwise-folding process of apoMb has been suggested in the following
order; helices G, A, H, B, E, C and D. During this folding pathway, there
are two folding intermediates, if one of these intermediates is mis-
folded, aggregation occurs. We can imagine that the folding of the
circular permutated globin of ADGB, where helices A and B are placed
after helices C-H, is more complicated than the folding of a typical
globin with a normal consecution of the helices, like NGB.
Previously, the eﬀect of circular permutation in Mb was investigated
by Ribeiro et al. [29]. A circular permutated Mb was engineered, where
helices A and B were shifted towards the C-terminus (similar to the
globin domain of ADGB). Subsequently, this protein was expressed in
E.coli as inclusion bodies and it was afterwards refolded in vitro. The
refolded circular permutated myoglobin displayed absorption spectra
similar to the WT Mb. However, the circular permutation caused a
signiﬁcant decrease in the stability of the protein and a large fraction
formed stable aggregates, similar to our experience with the circular
permutated globin domain of ADGB.
Most plausible, the globin domain of ADGB needs long-range in-
teractions from the amino acid sequence of the full-length ADGB to
form a stable globin fold. Another possibility is that the human globin
domain is simply not able to fold correctly in the prokaryotic E.coli
system. Therefore, we further investigated whether the globin domain
can be natively folded in an eukaryotic yeast expression system.
Recombinant expression in Pichia pastoris
E.coli as expression system might be the obvious ﬁrst choice, but it is
not always the best choice, as we have seen for CH-IQ-AB. E.coli is a
prokaryotic system and does not contain the subcellular machinery of
eukaryotes needed for post-translational modiﬁcations, including pro-
teolytic processing, folding, disulﬁde bond formation, glycosylation and
phosphorylation. Many eukaryotic proteins need to be modiﬁed fol-
lowing translation in order to become active and/or adapt the proper
structure. Yeast is an eukaryotic organism and, similar to E.coli, can be
grown to very high densities, which makes them especially useful for
large scale protein production. The two most common yeast strains
used for recombinant protein expression are S.cerevisiae and the me-
thylotrophic yeast P.pastoris.
Only few cases are reported where globins are recombinantly ex-
pressed in a yeast system [30–32]. An example of a globin that has been
successfully expressed in P.pastoris is the Crocodylus siamensis he-
moglobin. This crocodile Hb displays potent antibacterial and anti-in-
ﬂammation activity, as well as strong antioxidant properties [33–35].
Furthermore, it comprises six cysteine residues in the α-globin chain
and three cysteine residues in the β-globin chain [35]. Each of these
cysteine residues can form disulﬁde bonds both of the intermolecular
and intramolecular formation. The expression in E.coli resulted in low
expression yields and precipitation after puriﬁcation [32]. To overcome
these problems the crocodile Hb was successfully expressed in P.pas-
toris.
As the CH-IQ-AB globin domain of ADGB displays similar problems
of precipitation after puriﬁcation and comprises also three cysteine
residues (two in the α-helices and one in the IQ motif). We re-
combinantly expressed CH-IQ-AB in the P.pastoris system.
Expression of NGB and CH-IQ-AB in P.pastoris
For the expression of NGB and CH-IQ-AB we chose for methylo-
trophic yeast P.pastoris because it is widely used, cost-eﬀective and
suitable for large-scale protein production. cDNA of NGB and CH-IQ-AB
were cloned into the pPicZα vector, which places a native S.cerevisiae α-
secretion signal before the recombinant protein. The advantage of a
secreted expression is that P.pastoris secretes very low levels of native
proteins, facilitating further puriﬁcation steps. The pPicZα vector uses
the AOX promoter for a high-level, methanol-induced expression. After
induction of recombinant expression, every 24 h a sample was taken for
analysis of expression of CH-IQ-AB and NGB using western blot. NGB is
expressed and secreted by P.pastoris (Fig. 2A). 96 h post-induction, NGB
was puriﬁed out of the expression medium and optical absorption
spectra were taken (Fig. 2B). These spectra evidence proper folding and
incorporation of heme in NGB in line with previous descriptions [31].
Despite our eﬀorts to optimize the cDNA sequence of CH-IQ-AB to the
codon usage of P.pastoris, we could not detect recombinant expression
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of CH-IQ-AB in P.pastoris (Fig. 2A), neither in the secreted fraction nor
in the intracellular fraction.
This may be explained by the possibility that CH-IQ-AB cannot be
expressed as a stable soluble form because it requires the context of the
full length ADGB protein for proper folding as was previously sug-
gested. In E.coli, misfolded proteins are stored as inclusion bodies. In
eukaryotic systems, protein folding occurs in a diﬀerent way; proteins
are folded and processed in the endoplasmic reticulum (ER) and/or the
Golgi apparatus and sometimes secreted into the extracellular en-
vironment through vesicular transport (as is in the case of recombinant
expression of CH-IQ-AB in P.pastoris). In eukaryotes aberrant folding
properties of the target protein and/or high level production can lead to
the accumulation of unfolded or even aggregated protein in the ER,
which can initiate the unfolded protein response (UPR) and ER-asso-
ciated degradation [36–40]. This can thus possibly explain the fact that
we cannot detect expression of CH-IQ-AB in P.pastoris.
Recombinant expression in Sf9 insect cells
Finally, we opted for a third expression system, one that is much
closer to mammalian cells; the baculovirus-insect cell system. This ex-
pression system is a binary system, consisting of a recombinant bacu-
lovirus as the vector and lepidopteran insect cells as the host [41].
Insect cells represent a higher eukaryotic system than yeast; they are
able to carry out more complex post-translational modiﬁcations and
have a better folding machinery for mammalian proteins. Furthermore,
baculoviral vectors can accommodate large DNA inserts, which allows
for the production of multi-subunit protein complexes or even high
molecular weight virus-like particles [42–44]. A potential disadvantage
of the baculovirus-insect system is that it is a high-cost and time-con-
suming method of recombinant protein expression.
So far, there are no reports of globins recombinantly expressed in
insect cells. Since the baculovirus-insect cell expression system is
widely used for the recombinant expression of high molecular weight
proteins, we used it to express the 190 kDa full length ADGB protein.
Expression of NGB, CH-IQ-AB and full length ADGB in Sf9 cells
NGB, CH-IQ-AB and full length ADGB cDNA were cloned into the
pDEST10 vector, which possesses the strong transcriptional promoter
derived from the very late baculovirus gene polyhedrin, able to produce
milligrams of proteins. Sf9 insect cells were infected with recombinant
NGB, CH-IQ-AB and ADGB baculovirus particles. 72 h after infection,
the expression of recombinant protein was analyzed with western blot
(Fig. 3). Expression was detected for NGB and ADGB. The expression
level of CH-IQ-AB was however very low, again possibly reﬂecting that
the globin domain would require the context of the full length ADGB for
proper folding.
Surprisingly, for NGB multiple bands were detected with western
blot analysis (Fig. 3A). It seems that NGB a) can be detected as dimer
and b) appears in three apparent molecular mass forms, in Sf9 insect
cells. The dimerization could not be prevented by heat denaturation or
addition of reducing agents, like β-mercaptoethanol or DTT. Dimer-
ization was also seen for NGB when it was expressed in E.coli, but not in
P.pastoris (Fig. 4). In P.pastoris NGB is secreted into the medium, and is
Fig. 2. A) Western Blot analysis (anti His-tag) (15% polyacrylamide) of recombinant expression of NGB (∼19 kDa) and CH-IQ-AB (∼26 kDa) in X33 P.pastoris (pPicZα expression vector).
Expression was analyzed every 24 h post induction. Both soluble and insoluble fractions were analyzed. B) Optical absorption spectra of NGB, expressed in P.pastoris (pPicZα).
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thus present in lower concentrations than when it is intracellularly
expressed in E.coli or Sf9, dimer formation may in this way be con-
centration dependent. This phenomenon of dimerization, resistant to
heat denaturation and reduction, has been observed previously for Ngb
in whole protein extracts from mouse brain and retinas [45–48]. Fur-
thermore, it has been shown that three forms of apparent molecular
masses (∼17, ∼19 and ∼21 kDa), speciﬁcally recognized by anti-Ngb
antibodies, were identiﬁed in mitochondrial enriched fractions of
mouse retina [49]. This pattern of three diﬀerent molecular mass forms
is similar to the one that is seen after expression of NGB in Sf9 insect
cells (Fig. 3A). These forms might represent atypical migrations of
stable protein conformations and it has been hypothesized that rupture/
formation of the intra molecular (CD7-B5) disulﬁde bond of NGB [50]
can give rise to diﬀerent apparent molecular mass forms [49]. Post-
translational modiﬁcations could also occur, such as covalent links of
cofactors or phosphorylation. Indeed, it has previously been displayed
that Ngb is phosphorylated during hypoxia [51]. As insect cells are
known for their capabilities of protein N-glycosylation, we analyzed the
possibility that Ngb is N-glycosylated using the NetNGlyc1.0 prediction
server [52] and by the addition of PNGaseF, which enzymatically
cleaves N-glycans, to the cell lysate. No N-glycosylation sites were
predicted in NGB and PNGaseF did not cause a shift in molecular weight
on western blot, ruling out the possibility that NGB is N-glycosylated by
the insect cell system. It seems that NGB only forms these diﬀerent
molecular mass forms after expression in the higher eukaryotic bacu-
loviral insect cell system and not in E.coli or P.pastoris, assuming that
the latter do not provide the cellular environment for formation of these
diﬀerent conformations or post-translational modiﬁcations.
In contrast to the CH-IQ-AB domain, the full length ADGB was
signiﬁcantly expressed in Sf9 cells, conﬁrming the hypothesis that the
full length protein is required for stable expression. However, we ob-
served a time-dependent truncation of the full length protein (Fig. 3C)
and even after scaling-up the expression, the amount of full length
ADGB was insuﬃcient for further biophysical characterization. This
truncation is most probably a result of proteolysis by intracellular
proteases or by auto-cleavage by the N-terminal calpain-like domain, a
phenomenon commonly observed among calpains [53–56]. To further
evaluate if ADGB autolytic activity would be the source of this potential
auto-cleavage we added three diﬀerent protease inhibitors to the
growth medium; the cysteine protease inhibitor E64, the acid protease
inhibitor Pepstatin A and the calpain speciﬁc Calpain II inhibitor.
However, administration of these inhibitors did not prevent the trun-
cation of ADGB. The ADGB calpain-like domain is homologous to cal-
pain 7, for which no speciﬁc protease inhibitors exists. Interestingly,
substantial autolytic activity has also been demonstrated for calpain-7
[57]. Further research is necessary to understand this putative auto-
cleavage of ADGB.
Conclusion
In this paper we explored three diﬀerent expression systems for the
recombinant expression of globins; the prokaryote expression system
E.coli and the two eukaryote expression systems P.pastoris and baculo-
virus infected Sf9. In general, globins are small globular proteins, which
do not need post-translation modiﬁcation for a proper folding and in
this regard E.coli is the obvious ﬁrst choice for recombinant expression.
However, the major disadvantage of recombinant expression in E.coli is
the formation of insoluble aggregates, inclusion bodies.
We attempted to express the circular permutated globin domain of
ADGB in E.coli, P.pastoris and Sf9 cells, however, a soluble expression
was not possible. This suggest that the globin domain of ADGB needs
the full context of the full length protein in order to form a stable globin
fold. Furthermore, we displayed that ADGB was truncated, possibly due
Fig. 3. A) Western blot analysis (anti His tag) (15% polyacrylamide) of Sf9 cell lysate (soluble fraction) infected with recombinant NGB baculovirus particles. Expected molecular weight
of NGB is∼21 kDa. Multiple bands are detected, most probably caused by dimerization and formation of diﬀerent stable protein conformations or by post-translational modiﬁcations. B)
Western blot analysis (anti His tag) (15% polyacrylamide) of Sf9 cell lysate (soluble fraction) infected with recombinant CH-IQ-AB baculovirus particles. Expected molecular weight of
CH-IQ-AB is∼28 kDa. C) Western blot analysis (anti ADGB) (7,5% polyacrylamide) of Sf9 cell lysate (soluble fraction) infected with recombinant ADGB baculovirus particles. Expected
molecular weight of ADGB is ∼194 kDa. ADGB might be (auto)cleaved by internal proteases or by the N-terminal calpain domain of ADGB. BL = Blanc, uninfected Sf9 cell lysate.
Fig. 4. Western blot analysis (anti-His tag) (15% polyacrylamide) of E.coli, P.pastoris and
Sf9 cell lysates were NGB was recombinantly in expressed. Molecular weight of NGB in
E.coli should be∼18 kDa, in P.pastoris∼19 kDa and in Sf9∼21 kDa, due to diﬀerent C-
terminal or N-terminal His-tags. Dimerization of NGB resistant to heat denaturation and
reducing agents is seen in both E.coli and Sf9, not in P.pastoris. In Sf9 NGB appears in three
apparent molecular weight forms, possibly due to the formation of diﬀerent stable protein
conformations or by post-translational processing. This is not seen in E.coli or P.pastoris.
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to auto-cleavage by the internal calpain-like domain. Our study de-
monstrates that it is not always possible to express globins in E.coli and
that switching to a (higher) eukaryotic expression system might re-
present a valid alternative for more complex, multi-domain globins, like
the chimeric globin ADGB.
When NGB was recombinantly expressed in insect cells, three ap-
parent molecular mass forms and dimerization were observed, this was
not observed in E.coli or P.pastoris. Interestingly, the same multiple
band pattern on western blot has been observed in mitochondrial en-
riched fractions of mouse retina and in brain tissue. It seems that the
baculoviral insect cell expression system provides a cellular environ-
ment for folding and processing of proteins that is more similar to the
natural context of Ngb (brain and retina) compared to the cellular en-
vironments of E.coli or P.pastoris. In this regard it might be worthwhile
to switch to a (higher) eukaryotic expression systems for eukaryotic
proteins in general, even if they are easily expressed in a bacterial or
yeast expression system.
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